Mydecine Innovations Group to Acquire NeuroPharm Inc.

Strategically Positioned on Therapies for Military, Veterans, Front-Line Personnel Globally to cope with Mental Health & Well-Being June 10, 2020 /PRNewswire/ — Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) (“Mydecine” or the “Company”), is pleased to announce it has signed a non-binding Letter of Intent (“LOI”) dated June 9, 2020 to acquire NeuroPharm Inc., (“NeuroPharm”) aContinue reading “Mydecine Innovations Group to Acquire NeuroPharm Inc.”

Newleaf Brands Announces its Move into State-of-the-art 7,500 sq. ft. Specialty Mycology R&D and Product Development Lab in Denver, Colorado

VANCOUVER, British Columbia, June 2, 2020 /CNW/ —  NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) (“NewLeaf Brands” or the “Company“), soon to put into effect its name change to Mydecine Group, is pleased to announce the completion of its wholly-owned and operated world class R&D Lab and Facilities focused on the mycology of the  fungtional© mushroom space. Earlier lastContinue reading “Newleaf Brands Announces its Move into State-of-the-art 7,500 sq. ft. Specialty Mycology R&D and Product Development Lab in Denver, Colorado”

Newleaf Brands Announces Newest Newleaf Brands Advisor Appointee, Dr. Aubrey Oliver, set to Spearhead Jamaican-based Psilocybin Healing Retreat Efforts

VANCOUVER, British Columbia, May 26, 2020 /PRNewswire/ — NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) (“NewLeaf Brands” or the “Company“) is pleased to announce that it has officially appointed Dr. Aubrey Oliver ND, RBT to be its newest advisor. Dr. Oliver is a Jamaican registered Functional Holistic doctor and a graduate of Ashford University in Complementary and Alternative Medicine. InContinue reading “Newleaf Brands Announces Newest Newleaf Brands Advisor Appointee, Dr. Aubrey Oliver, set to Spearhead Jamaican-based Psilocybin Healing Retreat Efforts”

NewLeaf Brands Announces Appointment of Former Manager of Ebbu & Co-founder of Mydecine, Damon Michaels, to the Role of Chief Operations Officer (“COO”)

VANCOUVER, British Columbia, May 11, 2020 /CNW/ — NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE:0NF) (“NewLeaf Brands” or the “Company“) is pleased to announce that it has appointed Damon Michaels to the position of Chief Operations Officer (COO). Mr. Michaels previously served on the management team of Ebbu, a leading multi-platform cannabinoid research and technology firm based in Colorado. Prior to Ebbu’sContinue reading “NewLeaf Brands Announces Appointment of Former Manager of Ebbu & Co-founder of Mydecine, Damon Michaels, to the Role of Chief Operations Officer (“COO”)”

NewLeaf Brands Inc. Signs Definitive Agreement to Acquire 37.5% of Trellis Holdings and Comments on Initiative Petition 34 to Legalize Psilocybin Therapy in Oregon

VANCOUVER, BC, May 7, 2020 /CNW/ — NewLeaf Brands Inc. (CSE: NLB) (OTC: NLBIF) (FSE: 0NF) (“NewLeaf Brands” or the “Company”) is pleased to announce that it has signed a definitive agreement (the “Agreement’) dated May 5, 2020 with Trellis Holdings Oregon, LLC (“Trellis”) to acquire 37.5% of the issued and outstanding share capital of Trellis Holdings Oregon Op LLC (“Trellis”) from DavidContinue reading “NewLeaf Brands Inc. Signs Definitive Agreement to Acquire 37.5% of Trellis Holdings and Comments on Initiative Petition 34 to Legalize Psilocybin Therapy in Oregon”